Narrow Results Clear All
Search results for ""
Journal Article > Study
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. N Engl J Med. 2006;354:2443-2451.
This U.S. Food and Drug Administration (FDA)– and AHRQ–funded study documents the possibility of adverse effects on the fetus when mothers take angiotensin-converting enzyme (ACE) inhibitors during the first trimester of pregnancy.
Landro L. Wall Street Journal. July 12, 2006:D1. [Reprinted on Post-gazette.com].
This article reports on efforts to reduce use of certain medications and instruments that can cause harm during labor and delivery.
Clark C. HealthLeaders Media. September 13, 2013.
This news piece highlights concern around the safety of elective premature deliveries and describes techniques organizations have used to prevent such procedures.